Cargando…

Intradermal immunization—a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?

Detalles Bibliográficos
Autores principales: Schnyder, Jenny L., de Jong, Hanna K., Grobusch, Martin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403337/
https://www.ncbi.nlm.nih.gov/pubmed/34469811
http://dx.doi.org/10.1016/j.cmi.2021.08.020
_version_ 1783745979909931008
author Schnyder, Jenny L.
de Jong, Hanna K.
Grobusch, Martin P.
author_facet Schnyder, Jenny L.
de Jong, Hanna K.
Grobusch, Martin P.
author_sort Schnyder, Jenny L.
collection PubMed
description
format Online
Article
Text
id pubmed-8403337
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-84033372021-08-30 Intradermal immunization—a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines? Schnyder, Jenny L. de Jong, Hanna K. Grobusch, Martin P. Clin Microbiol Infect Commentary European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-01 2021-08-29 /pmc/articles/PMC8403337/ /pubmed/34469811 http://dx.doi.org/10.1016/j.cmi.2021.08.020 Text en © 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Schnyder, Jenny L.
de Jong, Hanna K.
Grobusch, Martin P.
Intradermal immunization—a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?
title Intradermal immunization—a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?
title_full Intradermal immunization—a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?
title_fullStr Intradermal immunization—a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?
title_full_unstemmed Intradermal immunization—a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?
title_short Intradermal immunization—a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?
title_sort intradermal immunization—a dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403337/
https://www.ncbi.nlm.nih.gov/pubmed/34469811
http://dx.doi.org/10.1016/j.cmi.2021.08.020
work_keys_str_mv AT schnyderjennyl intradermalimmunizationadosesparingstrategytocombatglobalshortagesofsevereacuterespiratorysyndromecoronavirus2vaccines
AT dejonghannak intradermalimmunizationadosesparingstrategytocombatglobalshortagesofsevereacuterespiratorysyndromecoronavirus2vaccines
AT grobuschmartinp intradermalimmunizationadosesparingstrategytocombatglobalshortagesofsevereacuterespiratorysyndromecoronavirus2vaccines